Hormones & Cancer-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2240120, encodeId=3e1f2240120e6, content=一本专注于肿瘤学研究的开放获取期刊。该期刊提供简便的投稿流程和快速的评审服务，大部分文章在1-2个月内被接受，审稿速度较快，版面费相对较低，性价比比较高。 对于希望快速发表研究成果的研究者来说是一个很大的优势。 但期刊的发文量较低，有可能竞争可能较小，被接受的机会就大了一些；对于希望快速发表，但对影响因子没太多要求的可以来试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:30:34 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2144610, encodeId=049821446109e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物，分子生物;肿瘤;生信分析 经验分享：已经改名discovery oncology，官网说初审3天，已经7天了，没有消息，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Sun Jun 25 10:58:25 CST 2023, time=2023-06-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2192318, encodeId=d827219231887, content=技术审查已经过了四个月了，一点消息都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8db8225594, createdName=ms7000000025099510, createdTime=Sat Mar 09 23:59:05 CST 2024, time=2024-03-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2157808, encodeId=73ae215e80826, content=Initial technical check都21天了，还没有动静。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Iiaml2UbHXGORLCB6yjcA3siahzkAlrsL10ic5HpBKNzEaOJvOKpYqH5MWzYASOgMkP6AsOtibp1K0XXosBKjSA7sg/132, createdBy=c3382256530, createdName=喵喵.com, createdTime=Fri Sep 15 09:59:57 CST 2023, time=2023-09-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189765, encodeId=7a772189e652a, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一审4个月修回，两次显示 Revised Quality Check要求修格式和图形摘要问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Tue Feb 27 22:35:49 CST 2024, time=2024-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2176067, encodeId=55b921e6067a9, content=审稿速度:6.0 经验分享：这个杂志好奇怪，第一次投稿SCI，14号显示1 Reviewer(s) accepted Awaiting their report，今天看状态没变，但变成9小时前了，是增加一位审稿人了吗，还是之前的不审了重新邀请的啊？有没有中的大佬解答一下，毕业用好担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee235687562, createdName=ms9000001505387034, createdTime=Wed Dec 20 10:44:25 CST 2023, time=2023-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2146705, encodeId=39872146e05a1, content=想问下这个杂志怎么撤稿呀，一个月了还是initial technical check,发了好几次邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26c88438756, createdName=ms7000000619671915, createdTime=Thu Jul 06 22:46:50 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174835, encodeId=16b621e483509, content=偏重的研究方向：肿瘤 经验分享：相比来说，我就比较好运，技术检查了一天半就过了，然后一天就分配了编辑，三天编辑就邀请审稿人了，目前外审半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd069039656, createdName=ms6000000198285398, createdTime=Thu Dec 14 00:06:56 CST 2023, time=2023-12-14, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2174273, encodeId=ad0121e4273e8, content=它这个中科院2区是怎么上的？有懂行的战友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=41605478147, createdName=ms1000000401634016, createdTime=Mon Dec 11 15:03:36 CST 2023, time=2023-12-11, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2174396, encodeId=599521e4396eb, content=开始邀请20个审稿人，后又改成40个审稿人，几天后又变成指定编辑了，各位大神知道咋会事吗？多谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a24661695, createdName=liangshoulei, createdTime=Tue Dec 12 09:35:51 CST 2023, time=2023-12-12, status=1, ipAttribution=河北省)]

2024-11-30 ms2000001788822132 来自上海

一本专注于肿瘤学研究的开放获取期刊。该期刊提供简便的投稿流程和快速的评审服务，大部分文章在1-2个月内被接受，审稿速度较快，版面费相对较低，性价比比较高。
对于希望快速发表研究成果的研究者来说是一个很大的优势。
但期刊的发文量较低，有可能竞争可能较小，被接受的机会就大了一些；对于希望快速发表，但对影响因子没太多要求的可以来试试。

29 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240120, encodeId=3e1f2240120e6, content=一本专注于肿瘤学研究的开放获取期刊。该期刊提供简便的投稿流程和快速的评审服务，大部分文章在1-2个月内被接受，审稿速度较快，版面费相对较低，性价比比较高。 对于希望快速发表研究成果的研究者来说是一个很大的优势。 但期刊的发文量较低，有可能竞争可能较小，被接受的机会就大了一些；对于希望快速发表，但对影响因子没太多要求的可以来试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:30:34 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2144610, encodeId=049821446109e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物，分子生物;肿瘤;生信分析 经验分享：已经改名discovery oncology，官网说初审3天，已经7天了，没有消息，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Sun Jun 25 10:58:25 CST 2023, time=2023-06-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2192318, encodeId=d827219231887, content=技术审查已经过了四个月了，一点消息都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8db8225594, createdName=ms7000000025099510, createdTime=Sat Mar 09 23:59:05 CST 2024, time=2024-03-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2157808, encodeId=73ae215e80826, content=Initial technical check都21天了，还没有动静。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Iiaml2UbHXGORLCB6yjcA3siahzkAlrsL10ic5HpBKNzEaOJvOKpYqH5MWzYASOgMkP6AsOtibp1K0XXosBKjSA7sg/132, createdBy=c3382256530, createdName=喵喵.com, createdTime=Fri Sep 15 09:59:57 CST 2023, time=2023-09-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189765, encodeId=7a772189e652a, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一审4个月修回，两次显示 Revised Quality Check要求修格式和图形摘要问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Tue Feb 27 22:35:49 CST 2024, time=2024-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2176067, encodeId=55b921e6067a9, content=审稿速度:6.0 经验分享：这个杂志好奇怪，第一次投稿SCI，14号显示1 Reviewer(s) accepted Awaiting their report，今天看状态没变，但变成9小时前了，是增加一位审稿人了吗，还是之前的不审了重新邀请的啊？有没有中的大佬解答一下，毕业用好担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee235687562, createdName=ms9000001505387034, createdTime=Wed Dec 20 10:44:25 CST 2023, time=2023-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2146705, encodeId=39872146e05a1, content=想问下这个杂志怎么撤稿呀，一个月了还是initial technical check,发了好几次邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26c88438756, createdName=ms7000000619671915, createdTime=Thu Jul 06 22:46:50 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174835, encodeId=16b621e483509, content=偏重的研究方向：肿瘤 经验分享：相比来说，我就比较好运，技术检查了一天半就过了，然后一天就分配了编辑，三天编辑就邀请审稿人了，目前外审半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd069039656, createdName=ms6000000198285398, createdTime=Thu Dec 14 00:06:56 CST 2023, time=2023-12-14, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2174273, encodeId=ad0121e4273e8, content=它这个中科院2区是怎么上的？有懂行的战友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=41605478147, createdName=ms1000000401634016, createdTime=Mon Dec 11 15:03:36 CST 2023, time=2023-12-11, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2174396, encodeId=599521e4396eb, content=开始邀请20个审稿人，后又改成40个审稿人，几天后又变成指定编辑了，各位大神知道咋会事吗？多谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a24661695, createdName=liangshoulei, createdTime=Tue Dec 12 09:35:51 CST 2023, time=2023-12-12, status=1, ipAttribution=河北省)]

2023-06-25 ms5000000525566741 来自河南省

审稿速度:1.0 | 投稿命中率:75.0
偏重的研究方向：细胞生物，分子生物;肿瘤;生信分析
经验分享：已经改名discovery oncology，官网说初审3天，已经7天了，没有消息，感觉不妙

256 23 举报

展开23条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240120, encodeId=3e1f2240120e6, content=一本专注于肿瘤学研究的开放获取期刊。该期刊提供简便的投稿流程和快速的评审服务，大部分文章在1-2个月内被接受，审稿速度较快，版面费相对较低，性价比比较高。 对于希望快速发表研究成果的研究者来说是一个很大的优势。 但期刊的发文量较低，有可能竞争可能较小，被接受的机会就大了一些；对于希望快速发表，但对影响因子没太多要求的可以来试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:30:34 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2144610, encodeId=049821446109e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物，分子生物;肿瘤;生信分析 经验分享：已经改名discovery oncology，官网说初审3天，已经7天了，没有消息，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Sun Jun 25 10:58:25 CST 2023, time=2023-06-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2192318, encodeId=d827219231887, content=技术审查已经过了四个月了，一点消息都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8db8225594, createdName=ms7000000025099510, createdTime=Sat Mar 09 23:59:05 CST 2024, time=2024-03-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2157808, encodeId=73ae215e80826, content=Initial technical check都21天了，还没有动静。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Iiaml2UbHXGORLCB6yjcA3siahzkAlrsL10ic5HpBKNzEaOJvOKpYqH5MWzYASOgMkP6AsOtibp1K0XXosBKjSA7sg/132, createdBy=c3382256530, createdName=喵喵.com, createdTime=Fri Sep 15 09:59:57 CST 2023, time=2023-09-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189765, encodeId=7a772189e652a, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一审4个月修回，两次显示 Revised Quality Check要求修格式和图形摘要问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Tue Feb 27 22:35:49 CST 2024, time=2024-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2176067, encodeId=55b921e6067a9, content=审稿速度:6.0 经验分享：这个杂志好奇怪，第一次投稿SCI，14号显示1 Reviewer(s) accepted Awaiting their report，今天看状态没变，但变成9小时前了，是增加一位审稿人了吗，还是之前的不审了重新邀请的啊？有没有中的大佬解答一下，毕业用好担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee235687562, createdName=ms9000001505387034, createdTime=Wed Dec 20 10:44:25 CST 2023, time=2023-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2146705, encodeId=39872146e05a1, content=想问下这个杂志怎么撤稿呀，一个月了还是initial technical check,发了好几次邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26c88438756, createdName=ms7000000619671915, createdTime=Thu Jul 06 22:46:50 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174835, encodeId=16b621e483509, content=偏重的研究方向：肿瘤 经验分享：相比来说，我就比较好运，技术检查了一天半就过了，然后一天就分配了编辑，三天编辑就邀请审稿人了，目前外审半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd069039656, createdName=ms6000000198285398, createdTime=Thu Dec 14 00:06:56 CST 2023, time=2023-12-14, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2174273, encodeId=ad0121e4273e8, content=它这个中科院2区是怎么上的？有懂行的战友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=41605478147, createdName=ms1000000401634016, createdTime=Mon Dec 11 15:03:36 CST 2023, time=2023-12-11, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2174396, encodeId=599521e4396eb, content=开始邀请20个审稿人，后又改成40个审稿人，几天后又变成指定编辑了，各位大神知道咋会事吗？多谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a24661695, createdName=liangshoulei, createdTime=Tue Dec 12 09:35:51 CST 2023, time=2023-12-12, status=1, ipAttribution=河北省)]

2024-03-09 ms7000000025099510 来自河北省

技术审查已经过了四个月了，一点消息都没有。

242 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2240120, encodeId=3e1f2240120e6, content=一本专注于肿瘤学研究的开放获取期刊。该期刊提供简便的投稿流程和快速的评审服务，大部分文章在1-2个月内被接受，审稿速度较快，版面费相对较低，性价比比较高。 对于希望快速发表研究成果的研究者来说是一个很大的优势。 但期刊的发文量较低，有可能竞争可能较小，被接受的机会就大了一些；对于希望快速发表，但对影响因子没太多要求的可以来试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:30:34 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2144610, encodeId=049821446109e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物，分子生物;肿瘤;生信分析 经验分享：已经改名discovery oncology，官网说初审3天，已经7天了，没有消息，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Sun Jun 25 10:58:25 CST 2023, time=2023-06-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2192318, encodeId=d827219231887, content=技术审查已经过了四个月了，一点消息都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8db8225594, createdName=ms7000000025099510, createdTime=Sat Mar 09 23:59:05 CST 2024, time=2024-03-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2157808, encodeId=73ae215e80826, content=Initial technical check都21天了，还没有动静。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Iiaml2UbHXGORLCB6yjcA3siahzkAlrsL10ic5HpBKNzEaOJvOKpYqH5MWzYASOgMkP6AsOtibp1K0XXosBKjSA7sg/132, createdBy=c3382256530, createdName=喵喵.com, createdTime=Fri Sep 15 09:59:57 CST 2023, time=2023-09-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189765, encodeId=7a772189e652a, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一审4个月修回，两次显示 Revised Quality Check要求修格式和图形摘要问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Tue Feb 27 22:35:49 CST 2024, time=2024-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2176067, encodeId=55b921e6067a9, content=审稿速度:6.0 经验分享：这个杂志好奇怪，第一次投稿SCI，14号显示1 Reviewer(s) accepted Awaiting their report，今天看状态没变，但变成9小时前了，是增加一位审稿人了吗，还是之前的不审了重新邀请的啊？有没有中的大佬解答一下，毕业用好担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee235687562, createdName=ms9000001505387034, createdTime=Wed Dec 20 10:44:25 CST 2023, time=2023-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2146705, encodeId=39872146e05a1, content=想问下这个杂志怎么撤稿呀，一个月了还是initial technical check,发了好几次邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26c88438756, createdName=ms7000000619671915, createdTime=Thu Jul 06 22:46:50 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174835, encodeId=16b621e483509, content=偏重的研究方向：肿瘤 经验分享：相比来说，我就比较好运，技术检查了一天半就过了，然后一天就分配了编辑，三天编辑就邀请审稿人了，目前外审半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd069039656, createdName=ms6000000198285398, createdTime=Thu Dec 14 00:06:56 CST 2023, time=2023-12-14, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2174273, encodeId=ad0121e4273e8, content=它这个中科院2区是怎么上的？有懂行的战友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=41605478147, createdName=ms1000000401634016, createdTime=Mon Dec 11 15:03:36 CST 2023, time=2023-12-11, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2174396, encodeId=599521e4396eb, content=开始邀请20个审稿人，后又改成40个审稿人，几天后又变成指定编辑了，各位大神知道咋会事吗？多谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a24661695, createdName=liangshoulei, createdTime=Tue Dec 12 09:35:51 CST 2023, time=2023-12-12, status=1, ipAttribution=河北省)]

2023-09-15 喵喵.com 来自陕西省

Initial technical check都21天了，还没有动静。。。

254 23 举报

展开23条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240120, encodeId=3e1f2240120e6, content=一本专注于肿瘤学研究的开放获取期刊。该期刊提供简便的投稿流程和快速的评审服务，大部分文章在1-2个月内被接受，审稿速度较快，版面费相对较低，性价比比较高。 对于希望快速发表研究成果的研究者来说是一个很大的优势。 但期刊的发文量较低，有可能竞争可能较小，被接受的机会就大了一些；对于希望快速发表，但对影响因子没太多要求的可以来试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:30:34 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2144610, encodeId=049821446109e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物，分子生物;肿瘤;生信分析 经验分享：已经改名discovery oncology，官网说初审3天，已经7天了，没有消息，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Sun Jun 25 10:58:25 CST 2023, time=2023-06-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2192318, encodeId=d827219231887, content=技术审查已经过了四个月了，一点消息都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8db8225594, createdName=ms7000000025099510, createdTime=Sat Mar 09 23:59:05 CST 2024, time=2024-03-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2157808, encodeId=73ae215e80826, content=Initial technical check都21天了，还没有动静。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Iiaml2UbHXGORLCB6yjcA3siahzkAlrsL10ic5HpBKNzEaOJvOKpYqH5MWzYASOgMkP6AsOtibp1K0XXosBKjSA7sg/132, createdBy=c3382256530, createdName=喵喵.com, createdTime=Fri Sep 15 09:59:57 CST 2023, time=2023-09-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189765, encodeId=7a772189e652a, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一审4个月修回，两次显示 Revised Quality Check要求修格式和图形摘要问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Tue Feb 27 22:35:49 CST 2024, time=2024-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2176067, encodeId=55b921e6067a9, content=审稿速度:6.0 经验分享：这个杂志好奇怪，第一次投稿SCI，14号显示1 Reviewer(s) accepted Awaiting their report，今天看状态没变，但变成9小时前了，是增加一位审稿人了吗，还是之前的不审了重新邀请的啊？有没有中的大佬解答一下，毕业用好担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee235687562, createdName=ms9000001505387034, createdTime=Wed Dec 20 10:44:25 CST 2023, time=2023-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2146705, encodeId=39872146e05a1, content=想问下这个杂志怎么撤稿呀，一个月了还是initial technical check,发了好几次邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26c88438756, createdName=ms7000000619671915, createdTime=Thu Jul 06 22:46:50 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174835, encodeId=16b621e483509, content=偏重的研究方向：肿瘤 经验分享：相比来说，我就比较好运，技术检查了一天半就过了，然后一天就分配了编辑，三天编辑就邀请审稿人了，目前外审半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd069039656, createdName=ms6000000198285398, createdTime=Thu Dec 14 00:06:56 CST 2023, time=2023-12-14, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2174273, encodeId=ad0121e4273e8, content=它这个中科院2区是怎么上的？有懂行的战友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=41605478147, createdName=ms1000000401634016, createdTime=Mon Dec 11 15:03:36 CST 2023, time=2023-12-11, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2174396, encodeId=599521e4396eb, content=开始邀请20个审稿人，后又改成40个审稿人，几天后又变成指定编辑了，各位大神知道咋会事吗？多谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a24661695, createdName=liangshoulei, createdTime=Tue Dec 12 09:35:51 CST 2023, time=2023-12-12, status=1, ipAttribution=河北省)]

2024-02-27 hongzhongshi 来自福建省

投稿命中率:50.0
偏重的研究方向：肿瘤
经验分享：一审4个月修回，两次显示 Revised Quality Check要求修格式和图形摘要问题

241 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2240120, encodeId=3e1f2240120e6, content=一本专注于肿瘤学研究的开放获取期刊。该期刊提供简便的投稿流程和快速的评审服务，大部分文章在1-2个月内被接受，审稿速度较快，版面费相对较低，性价比比较高。 对于希望快速发表研究成果的研究者来说是一个很大的优势。 但期刊的发文量较低，有可能竞争可能较小，被接受的机会就大了一些；对于希望快速发表，但对影响因子没太多要求的可以来试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:30:34 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2144610, encodeId=049821446109e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物，分子生物;肿瘤;生信分析 经验分享：已经改名discovery oncology，官网说初审3天，已经7天了，没有消息，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Sun Jun 25 10:58:25 CST 2023, time=2023-06-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2192318, encodeId=d827219231887, content=技术审查已经过了四个月了，一点消息都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8db8225594, createdName=ms7000000025099510, createdTime=Sat Mar 09 23:59:05 CST 2024, time=2024-03-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2157808, encodeId=73ae215e80826, content=Initial technical check都21天了，还没有动静。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Iiaml2UbHXGORLCB6yjcA3siahzkAlrsL10ic5HpBKNzEaOJvOKpYqH5MWzYASOgMkP6AsOtibp1K0XXosBKjSA7sg/132, createdBy=c3382256530, createdName=喵喵.com, createdTime=Fri Sep 15 09:59:57 CST 2023, time=2023-09-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189765, encodeId=7a772189e652a, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一审4个月修回，两次显示 Revised Quality Check要求修格式和图形摘要问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Tue Feb 27 22:35:49 CST 2024, time=2024-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2176067, encodeId=55b921e6067a9, content=审稿速度:6.0 经验分享：这个杂志好奇怪，第一次投稿SCI，14号显示1 Reviewer(s) accepted Awaiting their report，今天看状态没变，但变成9小时前了，是增加一位审稿人了吗，还是之前的不审了重新邀请的啊？有没有中的大佬解答一下，毕业用好担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee235687562, createdName=ms9000001505387034, createdTime=Wed Dec 20 10:44:25 CST 2023, time=2023-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2146705, encodeId=39872146e05a1, content=想问下这个杂志怎么撤稿呀，一个月了还是initial technical check,发了好几次邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26c88438756, createdName=ms7000000619671915, createdTime=Thu Jul 06 22:46:50 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174835, encodeId=16b621e483509, content=偏重的研究方向：肿瘤 经验分享：相比来说，我就比较好运，技术检查了一天半就过了，然后一天就分配了编辑，三天编辑就邀请审稿人了，目前外审半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd069039656, createdName=ms6000000198285398, createdTime=Thu Dec 14 00:06:56 CST 2023, time=2023-12-14, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2174273, encodeId=ad0121e4273e8, content=它这个中科院2区是怎么上的？有懂行的战友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=41605478147, createdName=ms1000000401634016, createdTime=Mon Dec 11 15:03:36 CST 2023, time=2023-12-11, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2174396, encodeId=599521e4396eb, content=开始邀请20个审稿人，后又改成40个审稿人，几天后又变成指定编辑了，各位大神知道咋会事吗？多谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a24661695, createdName=liangshoulei, createdTime=Tue Dec 12 09:35:51 CST 2023, time=2023-12-12, status=1, ipAttribution=河北省)]

2023-12-20 ms9000001505387034 来自福建省

审稿速度:6.0
经验分享：这个杂志好奇怪，第一次投稿SCI，14号显示1 Reviewer(s) accepted Awaiting their report，今天看状态没变，但变成9小时前了，是增加一位审稿人了吗，还是之前的不审了重新邀请的啊？有没有中的大佬解答一下，毕业用好担心

266 19 举报

展开19条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240120, encodeId=3e1f2240120e6, content=一本专注于肿瘤学研究的开放获取期刊。该期刊提供简便的投稿流程和快速的评审服务，大部分文章在1-2个月内被接受，审稿速度较快，版面费相对较低，性价比比较高。 对于希望快速发表研究成果的研究者来说是一个很大的优势。 但期刊的发文量较低，有可能竞争可能较小，被接受的机会就大了一些；对于希望快速发表，但对影响因子没太多要求的可以来试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:30:34 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2144610, encodeId=049821446109e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物，分子生物;肿瘤;生信分析 经验分享：已经改名discovery oncology，官网说初审3天，已经7天了，没有消息，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Sun Jun 25 10:58:25 CST 2023, time=2023-06-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2192318, encodeId=d827219231887, content=技术审查已经过了四个月了，一点消息都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8db8225594, createdName=ms7000000025099510, createdTime=Sat Mar 09 23:59:05 CST 2024, time=2024-03-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2157808, encodeId=73ae215e80826, content=Initial technical check都21天了，还没有动静。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Iiaml2UbHXGORLCB6yjcA3siahzkAlrsL10ic5HpBKNzEaOJvOKpYqH5MWzYASOgMkP6AsOtibp1K0XXosBKjSA7sg/132, createdBy=c3382256530, createdName=喵喵.com, createdTime=Fri Sep 15 09:59:57 CST 2023, time=2023-09-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189765, encodeId=7a772189e652a, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一审4个月修回，两次显示 Revised Quality Check要求修格式和图形摘要问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Tue Feb 27 22:35:49 CST 2024, time=2024-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2176067, encodeId=55b921e6067a9, content=审稿速度:6.0 经验分享：这个杂志好奇怪，第一次投稿SCI，14号显示1 Reviewer(s) accepted Awaiting their report，今天看状态没变，但变成9小时前了，是增加一位审稿人了吗，还是之前的不审了重新邀请的啊？有没有中的大佬解答一下，毕业用好担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee235687562, createdName=ms9000001505387034, createdTime=Wed Dec 20 10:44:25 CST 2023, time=2023-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2146705, encodeId=39872146e05a1, content=想问下这个杂志怎么撤稿呀，一个月了还是initial technical check,发了好几次邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26c88438756, createdName=ms7000000619671915, createdTime=Thu Jul 06 22:46:50 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174835, encodeId=16b621e483509, content=偏重的研究方向：肿瘤 经验分享：相比来说，我就比较好运，技术检查了一天半就过了，然后一天就分配了编辑，三天编辑就邀请审稿人了，目前外审半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd069039656, createdName=ms6000000198285398, createdTime=Thu Dec 14 00:06:56 CST 2023, time=2023-12-14, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2174273, encodeId=ad0121e4273e8, content=它这个中科院2区是怎么上的？有懂行的战友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=41605478147, createdName=ms1000000401634016, createdTime=Mon Dec 11 15:03:36 CST 2023, time=2023-12-11, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2174396, encodeId=599521e4396eb, content=开始邀请20个审稿人，后又改成40个审稿人，几天后又变成指定编辑了，各位大神知道咋会事吗？多谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a24661695, createdName=liangshoulei, createdTime=Tue Dec 12 09:35:51 CST 2023, time=2023-12-12, status=1, ipAttribution=河北省)]

2023-07-06 ms7000000619671915 来自广东省

想问下这个杂志怎么撤稿呀，一个月了还是initial technical check,发了好几次邮件也不回

249 9 举报

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240120, encodeId=3e1f2240120e6, content=一本专注于肿瘤学研究的开放获取期刊。该期刊提供简便的投稿流程和快速的评审服务，大部分文章在1-2个月内被接受，审稿速度较快，版面费相对较低，性价比比较高。 对于希望快速发表研究成果的研究者来说是一个很大的优势。 但期刊的发文量较低，有可能竞争可能较小，被接受的机会就大了一些；对于希望快速发表，但对影响因子没太多要求的可以来试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:30:34 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2144610, encodeId=049821446109e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物，分子生物;肿瘤;生信分析 经验分享：已经改名discovery oncology，官网说初审3天，已经7天了，没有消息，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Sun Jun 25 10:58:25 CST 2023, time=2023-06-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2192318, encodeId=d827219231887, content=技术审查已经过了四个月了，一点消息都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8db8225594, createdName=ms7000000025099510, createdTime=Sat Mar 09 23:59:05 CST 2024, time=2024-03-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2157808, encodeId=73ae215e80826, content=Initial technical check都21天了，还没有动静。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Iiaml2UbHXGORLCB6yjcA3siahzkAlrsL10ic5HpBKNzEaOJvOKpYqH5MWzYASOgMkP6AsOtibp1K0XXosBKjSA7sg/132, createdBy=c3382256530, createdName=喵喵.com, createdTime=Fri Sep 15 09:59:57 CST 2023, time=2023-09-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189765, encodeId=7a772189e652a, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一审4个月修回，两次显示 Revised Quality Check要求修格式和图形摘要问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Tue Feb 27 22:35:49 CST 2024, time=2024-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2176067, encodeId=55b921e6067a9, content=审稿速度:6.0 经验分享：这个杂志好奇怪，第一次投稿SCI，14号显示1 Reviewer(s) accepted Awaiting their report，今天看状态没变，但变成9小时前了，是增加一位审稿人了吗，还是之前的不审了重新邀请的啊？有没有中的大佬解答一下，毕业用好担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee235687562, createdName=ms9000001505387034, createdTime=Wed Dec 20 10:44:25 CST 2023, time=2023-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2146705, encodeId=39872146e05a1, content=想问下这个杂志怎么撤稿呀，一个月了还是initial technical check,发了好几次邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26c88438756, createdName=ms7000000619671915, createdTime=Thu Jul 06 22:46:50 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174835, encodeId=16b621e483509, content=偏重的研究方向：肿瘤 经验分享：相比来说，我就比较好运，技术检查了一天半就过了，然后一天就分配了编辑，三天编辑就邀请审稿人了，目前外审半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd069039656, createdName=ms6000000198285398, createdTime=Thu Dec 14 00:06:56 CST 2023, time=2023-12-14, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2174273, encodeId=ad0121e4273e8, content=它这个中科院2区是怎么上的？有懂行的战友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=41605478147, createdName=ms1000000401634016, createdTime=Mon Dec 11 15:03:36 CST 2023, time=2023-12-11, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2174396, encodeId=599521e4396eb, content=开始邀请20个审稿人，后又改成40个审稿人，几天后又变成指定编辑了，各位大神知道咋会事吗？多谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a24661695, createdName=liangshoulei, createdTime=Tue Dec 12 09:35:51 CST 2023, time=2023-12-12, status=1, ipAttribution=河北省)]

2023-12-14 ms6000000198285398 来自贵州省

偏重的研究方向：肿瘤
经验分享：相比来说，我就比较好运，技术检查了一天半就过了，然后一天就分配了编辑，三天编辑就邀请审稿人了，目前外审半个月。

241 2 举报

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240120, encodeId=3e1f2240120e6, content=一本专注于肿瘤学研究的开放获取期刊。该期刊提供简便的投稿流程和快速的评审服务，大部分文章在1-2个月内被接受，审稿速度较快，版面费相对较低，性价比比较高。 对于希望快速发表研究成果的研究者来说是一个很大的优势。 但期刊的发文量较低，有可能竞争可能较小，被接受的机会就大了一些；对于希望快速发表，但对影响因子没太多要求的可以来试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:30:34 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2144610, encodeId=049821446109e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物，分子生物;肿瘤;生信分析 经验分享：已经改名discovery oncology，官网说初审3天，已经7天了，没有消息，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Sun Jun 25 10:58:25 CST 2023, time=2023-06-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2192318, encodeId=d827219231887, content=技术审查已经过了四个月了，一点消息都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8db8225594, createdName=ms7000000025099510, createdTime=Sat Mar 09 23:59:05 CST 2024, time=2024-03-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2157808, encodeId=73ae215e80826, content=Initial technical check都21天了，还没有动静。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Iiaml2UbHXGORLCB6yjcA3siahzkAlrsL10ic5HpBKNzEaOJvOKpYqH5MWzYASOgMkP6AsOtibp1K0XXosBKjSA7sg/132, createdBy=c3382256530, createdName=喵喵.com, createdTime=Fri Sep 15 09:59:57 CST 2023, time=2023-09-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189765, encodeId=7a772189e652a, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一审4个月修回，两次显示 Revised Quality Check要求修格式和图形摘要问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Tue Feb 27 22:35:49 CST 2024, time=2024-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2176067, encodeId=55b921e6067a9, content=审稿速度:6.0 经验分享：这个杂志好奇怪，第一次投稿SCI，14号显示1 Reviewer(s) accepted Awaiting their report，今天看状态没变，但变成9小时前了，是增加一位审稿人了吗，还是之前的不审了重新邀请的啊？有没有中的大佬解答一下，毕业用好担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee235687562, createdName=ms9000001505387034, createdTime=Wed Dec 20 10:44:25 CST 2023, time=2023-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2146705, encodeId=39872146e05a1, content=想问下这个杂志怎么撤稿呀，一个月了还是initial technical check,发了好几次邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26c88438756, createdName=ms7000000619671915, createdTime=Thu Jul 06 22:46:50 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174835, encodeId=16b621e483509, content=偏重的研究方向：肿瘤 经验分享：相比来说，我就比较好运，技术检查了一天半就过了，然后一天就分配了编辑，三天编辑就邀请审稿人了，目前外审半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd069039656, createdName=ms6000000198285398, createdTime=Thu Dec 14 00:06:56 CST 2023, time=2023-12-14, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2174273, encodeId=ad0121e4273e8, content=它这个中科院2区是怎么上的？有懂行的战友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=41605478147, createdName=ms1000000401634016, createdTime=Mon Dec 11 15:03:36 CST 2023, time=2023-12-11, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2174396, encodeId=599521e4396eb, content=开始邀请20个审稿人，后又改成40个审稿人，几天后又变成指定编辑了，各位大神知道咋会事吗？多谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a24661695, createdName=liangshoulei, createdTime=Tue Dec 12 09:35:51 CST 2023, time=2023-12-12, status=1, ipAttribution=河北省)]

2023-12-11 ms1000000401634016 来自江西省

它这个中科院2区是怎么上的？有懂行的战友吗

269 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2240120, encodeId=3e1f2240120e6, content=一本专注于肿瘤学研究的开放获取期刊。该期刊提供简便的投稿流程和快速的评审服务，大部分文章在1-2个月内被接受，审稿速度较快，版面费相对较低，性价比比较高。 对于希望快速发表研究成果的研究者来说是一个很大的优势。 但期刊的发文量较低，有可能竞争可能较小，被接受的机会就大了一些；对于希望快速发表，但对影响因子没太多要求的可以来试试。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=29, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=520e8539624, createdName=ms2000001788822132, createdTime=Sat Nov 30 22:30:34 CST 2024, time=2024-11-30, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=2144610, encodeId=049821446109e, content=审稿速度:1.0 | 投稿命中率:75.0 偏重的研究方向：细胞生物，分子生物;肿瘤;生信分析 经验分享：已经改名discovery oncology，官网说初审3天，已经7天了，没有消息，感觉不妙, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f2315573864, createdName=ms5000000525566741, createdTime=Sun Jun 25 10:58:25 CST 2023, time=2023-06-25, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=2192318, encodeId=d827219231887, content=技术审查已经过了四个月了，一点消息都没有。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f8db8225594, createdName=ms7000000025099510, createdTime=Sat Mar 09 23:59:05 CST 2024, time=2024-03-09, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=2157808, encodeId=73ae215e80826, content=Initial technical check都21天了，还没有动静。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=254, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/Iiaml2UbHXGORLCB6yjcA3siahzkAlrsL10ic5HpBKNzEaOJvOKpYqH5MWzYASOgMkP6AsOtibp1K0XXosBKjSA7sg/132, createdBy=c3382256530, createdName=喵喵.com, createdTime=Fri Sep 15 09:59:57 CST 2023, time=2023-09-15, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2189765, encodeId=7a772189e652a, content=投稿命中率:50.0 偏重的研究方向：肿瘤 经验分享：一审4个月修回，两次显示 Revised Quality Check要求修格式和图形摘要问题, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=9fb55313293, createdName=hongzhongshi, createdTime=Tue Feb 27 22:35:49 CST 2024, time=2024-02-27, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2176067, encodeId=55b921e6067a9, content=审稿速度:6.0 经验分享：这个杂志好奇怪，第一次投稿SCI，14号显示1 Reviewer(s) accepted Awaiting their report，今天看状态没变，但变成9小时前了，是增加一位审稿人了吗，还是之前的不审了重新邀请的啊？有没有中的大佬解答一下，毕业用好担心, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee235687562, createdName=ms9000001505387034, createdTime=Wed Dec 20 10:44:25 CST 2023, time=2023-12-20, status=1, ipAttribution=福建省), GetPortalCommentsPageByObjectIdResponse(id=2146705, encodeId=39872146e05a1, content=想问下这个杂志怎么撤稿呀，一个月了还是initial technical check,发了好几次邮件也不回, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=249, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26c88438756, createdName=ms7000000619671915, createdTime=Thu Jul 06 22:46:50 CST 2023, time=2023-07-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2174835, encodeId=16b621e483509, content=偏重的研究方向：肿瘤 经验分享：相比来说，我就比较好运，技术检查了一天半就过了，然后一天就分配了编辑，三天编辑就邀请审稿人了，目前外审半个月。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=241, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cd069039656, createdName=ms6000000198285398, createdTime=Thu Dec 14 00:06:56 CST 2023, time=2023-12-14, status=1, ipAttribution=贵州省), GetPortalCommentsPageByObjectIdResponse(id=2174273, encodeId=ad0121e4273e8, content=它这个中科院2区是怎么上的？有懂行的战友吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=41605478147, createdName=ms1000000401634016, createdTime=Mon Dec 11 15:03:36 CST 2023, time=2023-12-11, status=1, ipAttribution=江西省), GetPortalCommentsPageByObjectIdResponse(id=2174396, encodeId=599521e4396eb, content=开始邀请20个审稿人，后又改成40个审稿人，几天后又变成指定编辑了，各位大神知道咋会事吗？多谢！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=242, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d3a24661695, createdName=liangshoulei, createdTime=Tue Dec 12 09:35:51 CST 2023, time=2023-12-12, status=1, ipAttribution=河北省)]

2023-12-12 liangshoulei 来自河北省

开始邀请20个审稿人，后又改成40个审稿人，几天后又变成指定编辑了，各位大神知道咋会事吗？多谢！

242 2 举报

展开2条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务